ライフサイエンスコーパス: prothrombin complex

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 pathway when FXa is well-saturated with the prothrombin complex.

2 es of the membrane-bound factor Xa-factor-Va-prothrombin complex.

3 nical trial to compare nonactivated 4-factor prothrombin complex concentrate (4F-PCC) with plasma for

4 pared the efficacy and safety of four-factor prothrombin complex concentrate (4F-PCC) with that of pl

5 measures and biomarkers by using a 4-factor prothrombin complex concentrate (4F-PCC).

6 efficacy of fresh frozen plasma (FFP) versus prothrombin complex concentrate (PCC) in patients with V

7 actice include fresh frozen plasma (FFP) and prothrombin complex concentrate (PCC).

8 therapies that promote formation of fibrin (prothrombin complex concentrate [PCC], activated PCC [aP

9 ecombinant activated factor VII or activated prothrombin complex concentrate did not alter the delaye

10 rventional treatment was needed in 37.8% and prothrombin complex concentrate in 9.1%.

11 circumstances, avoiding the use of plasma or prothrombin complex concentrate in the nonemergent rever

12 rgent reversal with frozen plasma versus the prothrombin complex concentrate Octaplex.

13 ntial hematoma expansion (43% [12 of 28] for prothrombin complex concentrate vs 29% [5 of 17] for no

14 ng administration of hemostatic factors (eg, prothrombin complex concentrate), were left to the discr

15 ntial ability of a low dose of the activated prothrombin complex concentrate, FEIBA, to reestablish h

16 complex concentrate vs 29% [5 of 17] for no prothrombin complex concentrate, P = .53), or on the occ

17 agents with a fast onset of action, such as prothrombin complex concentrate, recombinant factor VIIa

18 pplied to guide the dosing of fibrinogen and prothrombin complex concentrate, which are selectively u

19 all, 57% (35 of 61) of the patients received prothrombin complex concentrate, with no statistically s

20 rfarin anticoagulation with frozen plasma or prothrombin complex concentrate.

21 romboembolic events in patients treated with prothrombin complex concentrates (PCCs) for the manageme

22 Nonspecific hemostatic agents such as prothrombin complex concentrates and recombinant factor

23 xpanded available therapeutic options beyond prothrombin complex concentrates and their activated for

24 Recombinant factor VIIa and activated prothrombin complex concentrates are similarly effective

25 of coagulation factors (fresh frozen plasma, prothrombin complex concentrates or recombinant activate

26 he coagulation factor levels and contents of prothrombin complex concentrates; ambiguity about the op

27 therapy; the variability in availability of prothrombin complex concentrates; the variability in the

28 eal a function for autocatalysis of the vWbp.prothrombin complexes during initiation of blood coagula

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。